Literature DB >> 16568123

Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?

Patrick D Lyden1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568123     DOI: 10.1038/ncpcardio0511

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


× No keyword cloud information.
  3 in total

1.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

2.  A blinded, randomized study of L-arginine in small clot embolized rabbits.

Authors:  Paul A Lapchak; Jessica T Daley; Paul D Boitano
Journal:  Exp Neurol       Date:  2015-02-20       Impact factor: 5.330

3.  Safety and outcome of thrombolysis in mild stroke: a meta-analysis.

Authors:  Lei Shi; Min Zhang; Hengfang Liu; Bo Song; Changdong Song; Dandan Song; Yuming Xu
Journal:  Med Sci Monit       Date:  2014-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.